Coronary artery bypass grafting in patients with systemic lupus erythematosus

Nilgün Bozbuğa1, Vedat Erentuğ, Erhan Kaya

  • 1Department of Cardiovascular Surgery, Koşuyolu Heart and Research Hospital, Istanbul, Turkey. nbozbuga@kosuyolu.gov.tr

Journal of Cardiac Surgery
|September 24, 2004
PubMed

Insights

Systemic lupus erythematosus (SLE) patients can undergo successful coronary artery bypass grafting (CABG). Two SLE patients with coronary artery disease had good outcomes after CABG, one with cardiopulmonary bypass and another off-pump during hemodialysis.

Area of Science:

  • Cardiology
  • Rheumatology
  • Surgical Innovation

Background:

  • Coronary artery disease (CAD) is a significant cause of mortality in patients with systemic lupus erythematosus (SLE).
  • Surgical management of CAD in SLE patients presents unique challenges.
  • Limited data exists on the outcomes of coronary artery bypass grafting (CABG) in SLE patients.

Observation:

  • Two female SLE patients, aged 45 and 39, presented with significant coronary artery disease.
  • The first patient had left main and two-vessel coronary disease requiring CABG with cardiopulmonary bypass.
  • The second patient, undergoing hemodialysis, underwent successful off-pump CABG.

Findings:

  • Both SLE patients demonstrated successful outcomes following coronary artery bypass grafting.
  • The use of cardiopulmonary bypass and off-pump techniques were both feasible in this patient cohort.
  • Postoperative recovery was uncomplicated in both cases, suggesting good surgical tolerability.

Implications:

  • CABG is a viable and safe treatment option for selected SLE patients with coronary artery disease.
  • Off-pump CABG may be a suitable alternative, particularly for patients with comorbidities like those requiring hemodialysis.
  • Further research is warranted to establish optimal surgical strategies and long-term outcomes for SLE patients undergoing CABG.